Translational Psychiatry

Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.

News

Publications
Special Issue “Psychosis: Clinical Management and Challenges” – call for submissions
Publications
Increased Belief Instability in Psychotic Disorders Predicts Treatment Response to Metacognitive Training
Publications
Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
Publications
Clinical, Brain, and Multilevel Clustering in Early Psychosis and Affective Stages
Publications
Convolutional neural network propagation on electroencephalographic scalograms for detection of schizophrenia
Grants
Grant: Intelligent health solutions for digitally informed psychiatry 
01/03

Mission

We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.

02/03

About us

We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.

03/03

Research

Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.

Scroll to Top